Lafayette Family Cancer Center

Lafayette Hotels has pledged 2 million dollars to the Lafayette Family Cancer Center in Brewer, Maine – one million to help fund the building and one million to endow a fund to do cancer research.

The Lafayette Family of Hotels is committed to helping find cures at this world-class center in Maine. We believe that the Center will bring help and hope to cancer patients and their families.

Our 27 properties located in Maine and New Hampshire are all participating in fundraisers for this effort.

In 2017, the Lafayette Family Foundation donated $220,000 to the Lafayette Family Cancer Center and its collaborators for melanoma research. Doctors from the Cancer Center collaborate closely with colleagues from Jackson Lab in Bar Harbor, Maine; as well as Dana-Farber Cancer Institute in Boston, Massachusetts on joint research and studies. The Foundation to Cure Melanoma donated $30,000 in 2017.  $15,000 paid for a conference educating doctors about melanoma, and $10,000 to Jackson Lab and $5,000 to Dana-Farber for melanoma research. Total donations for the year were over $250,000.

This year’s Champion the Cure Challenge raised over $620,000 - all of the proceeds will stay local. The Lafayette Hotels team was the largest ever at 126 participants and raised over $75,000

EMMC is accredited through the American College of Surgeons and recognized for outstanding achievement. We are proud to offer many national clinical trials locally. EMMC CancerCare of Maine currently has over 80 adult and pediatric trials available. The modern facility is located in the Lafayette Family Cancer Center in Brewer. The Center is equipped with the most advanced cancer treatment technologies in northern New England as well as private and shared treatment areas, where families can join their loved ones receiving care.

EMMC Cancer Care has been selected as the only organization in Maine to become a member of the Dana-Farber Cancer Care Collaborative, a program that will bring many benefits to those affected by cancer in the community. In addition, EMHS has entered into an affiliation with Dana-Farber that will help bring leading-edge cancer treatments to surrounding communities throughout the state. Membership in the collaborative enhances educational opportunities for staff, and offers opportunities for consultation with medical specialists at Dana-Farber in Boston for complex cases. In addition, many of the latest Dana-Farber clinical trials will be available in Maine for patients at EMMC Cancer Care.